METASTATIC CUTANEOUS MELANOMA (STAGE IV)

Clinical trials for METASTATIC CUTANEOUS MELANOMA (STAGE IV) explained in plain language.

Never miss a new study

Get alerted when new METASTATIC CUTANEOUS MELANOMA (STAGE IV) trials appear

Sign up with your email to follow new studies for METASTATIC CUTANEOUS MELANOMA (STAGE IV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo tested for Tough-to-Treat skin cancer

Disease control Ongoing

This study is testing a new drug called acasunlimab, given alone or together with the cancer drug pembrolizumab, for people with advanced skin melanoma that has continued to grow despite prior immunotherapy. The main goal is to see if the treatment can shrink tumors and is safe. …

Matched conditions: METASTATIC CUTANEOUS MELANOMA (STAGE IV)

Phase: PHASE2 • Sponsor: Genmab • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

METASTATIC CUTANEOUS MELANOMA (STAGE IV)

Get alerted when new METASTATIC CUTANEOUS MELANOMA (STAGE IV) trials appear

New drug combo tested for Tough-to-Treat skin cancer